AmInvest Research Reports

Hap Seng Plantations - Strong FFB Output Growth

Publish date: Wed, 28 Feb 2024, 10:49 AM
0 8,727
An official blog in I3investor to publish research reports provided by AmInvest research team.

All materials published here are prepared by AmInvest. For latest offers on AmInvest trading products and news, please refer to:

Tel: +603 2036 1800 / +603 2032 2888
Fax: +603 2031 5210

Office Hours
Monday to Thursday: 8:45am – 5:45pm
Friday: 8:45am – 5:00pm
(GMT +08:00 Malaysia)

Investment Highlights

  • We maintain BUY on Hap Seng Plantations (HSP) with an unchanged fair value of RM2.30/share, based on FY24F PE of 15x, which is the 5-year average for small cap planters. We ascribe a neutral 3-star ESG rating to HSP.
  • HSP’s FY23 net profit of RM91.4mil was within our forecast and consensus. The group has declared a final gross DPS of 5.3 sen, which brings total gross DPS to 6.8 sen for FY23 (FY22: 12 sen). We forecast a gross DPS of 7 sen for FY24F, which translates into a yield of 3.8%.
  • HSP’s core net profit (ex-disposal gains of RM26.5mil in FY22) dived by 50.3% to RM91.4mil in FY23 due to weaker palm product prices and a higher cost of CPO production. On a positive note, HSP’s FFB production rose by 9.3% in FY23.
  • Average realised CPO price retreated by 28.2% to RM3,947/tonne in FY23 from RM5,530/tonne in FY22. Average palm kernel price plunged by 35% to RM2,155/tonne in FY23 from RM3,315/tonne in FY22.
  • HSP’s average CPO price of RM3,947/tonne was 5.6% higher than MPOB Sabah’s average price of RM3,739/tonne in FY23. We believe that this is due to the RSPO premium and the low levels of fatty acid in HSP’s CPO products.
  • Comparing 4QFY23 against 3QFY23, HSP’s net profit slid by 45.3% to RM20.7mil due to a fair value loss of RM21.1mil on biological assets. Operationally, HSP’s FFB output expanded by 13.7% QoQ in 4QFY23. Average CPO price realised was RM3,798/tonne in 4QFY23 compared to RM3,924/tonne in 3QFY23.
  • HSP is currently trading at a decent FY24F PE of 12x, lower than its 2-year peak of 18x. We believe that HSP should be accorded a premium due to the group’s FFB production growth, which is stronger than its peers.

Source: AmInvest Research - 28 Feb 2024

Related Stocks
Market Buzz
Be the first to like this. Showing 0 of 0 comments

Post a Comment